Search – Page 194 – Indianapolis Business Journal

Home » Search

Articles

Lilly launches obesity drug, but insurers balk over price

December 8, 2023 | John Russell

The new drug, called Zepbound, carries a hefty price of $1,059.87 per month, and insurers and health care plans are balking, questioning its affordability. Many employers and government health programs exclude obesity treatments from their coverage.

Lilly stock slips after study finds patients who stop Zepbound regain weight

December 11, 2023 | Bloomberg News

People who stopped taking Eli Lilly and Co.’s blockbuster drug Zepbound after about eight months regained half the weight they’d lost a year later, yet were significantly thinner than when they had started the obesity drug, according to a new study.

Mark Montieth: Remembering the basketball prowess and sunny kindness of George McGinnis

December 14, 2023 | Mark Montieth

It’s a cliché to say someone who just passed away, as basketball legend George McGinnis did early Thursday, was a good person. But he went beyond that. He was nice to a fault. So nice, in fact, that people took advantage of him.

Point Biopharma shares sink 11% on study results; Lilly acquisition still up in air

December 18, 2023 | John Russell

Results of a clinical trial for Point Biopharma’s lead compound fell short of analysts’ expectations, and that development is likely to pressure its investors to decide whether to agree to sell the company to Eli Lilly and Co. for $1.4 billion.

Point Biopharma headquarters (Photo courtesy of the company)

Lilly signs another AI deal, this one for obesity

December 22, 2023 | John Russell

Fauna Bio, based in the San Francisco area, said Thursday it will give Lilly access to its AI platform, called Convergence, to support preclinical drug discovery efforts in obesity.

Mark Williams: Let’s continue important conversation about creativity

December 22, 2023 | Mark Williams

We’re beginning a conversation that doesn’t assume that economics and creativity live in separate worlds. On the contrary, any successful businessperson will tell you that creativity is essential to success.

RayzeBio Inc. to be acquired by drugmaker Bristol Myers Squibb for $4.1B

December 26, 2023 | John Russell

RayzeBio is building a large factory on the northwest side of Indianapolis to make radioisotopes for cancer treatment.

Lilly’s soaring stock, Fishers’ innovation park among top 10 life sciences stories of 2023

December 27, 2023 | John Russell

It was a busy year for the Indiana life sciences community, with a flurry of billion-dollar deals, major announcements, and a few setbacks. Here we present the top 10 stories of 2023—the good, the bad and the ugly—about an industry that is often hailed as a key driver of Indiana’s economy.

Legislative push brewing to make new weight loss drugs more accessible

December 29, 2023 | Associated Press

Obesity drugs like Wegovy and Eli Lilly’s Zepbound are showing promising results in helping people shed pounds. But a law bans Medicare from paying for weight loss drugs. Now, drugmakers and a bipartisan coalition of lawmakers are gearing up to push for that to change next year.

Q&A: Indy Chamber’s new CEO Matt Mindrum

December 29, 2023 | Peter Blanchard

Matt Mindrum is a month into his new role and recently spoke with IBJ about his vision for the region’s growth, downtown vitality and his new insights into youth apprenticeships.

2023 Newsmaker: Ricks leads Lilly to new heights

December 29, 2023 | John Russell

David Ricks led Eli Lilly and Co. to milestone after milestone in 2023, with a slew of product launches for diseases from obesity to inflammatory bowel disease. And when Lilly wasn’t scoring wins in the laboratory, it was issuing a series of head-turning announcements,

2023 Year in Review: Lilly had a ‘big-deal’ year

December 29, 2023 | Susan Orr

Among other big dealmakers in 2023 was Hillenbrand Inc., Jasper-based Kimball International Inc. and Noblesville-based Helmer Scientific Inc.

2023 Year in Review: LEAP District stirs debate in Indiana communities

December 29, 2023 | Peter Blanchard

The LEAP Research and Innovation District under development near Lebanon represents a shift in the way the Indiana Economic Development Corp., the public-private state agency overseeing the project, is working to attract companies and create jobs.

Nevada company sues Lilly for breach of contract over Alzheimer’s drug

January 3, 2024 | John Russell

Lilly called the lawsuit “baseless” and said PDL BioPharma “has no plausible claim to royalties” for donanemab, which is expected to be approved by the FDA this quarter.

Lilly launches online service that offers home delivery of weight-loss, diabetes, migraine drugs

January 4, 2024 | IBJ Staff and Bloomberg News

Among the medications listed as available through LillyDirect Pharmacy Services is Zepbound, the company’s popular new weight loss treatment, which is projected to exceed $2 billion in sales in 2024.

Report: Indianapolis tops Midwestern cities in three-year GDP growth

January 4, 2024 | Taylor Wooten and Mickey Shuey

Indianapolis surpassed its Midwestern peers in gross domestic product growth from 2019 to 2022, according to a report from a Washington, D.C.-based economist.

Report: Indiana lagging nation in life sciences sector growth

January 8, 2024 | John Russell

Indiana’s pharmaceutical and medical device sectors, long touted as major contributors to the state’s economy, are starting to lag the nation in growth and market share and will require a focused effort to stay competitive, according to a new report released Monday.

« Previous 1 … 192 193 194 195 196 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'